Donald Bellgrau

3.3k total citations · 1 hit paper
78 papers, 2.7k citations indexed

About

Donald Bellgrau is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Donald Bellgrau has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 24 papers in Genetics and 21 papers in Molecular Biology. Recurrent topics in Donald Bellgrau's work include Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (23 papers). Donald Bellgrau is often cited by papers focused on Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (26 papers) and Immunotherapy and Immune Responses (23 papers). Donald Bellgrau collaborates with scholars based in United States, Australia and Switzerland. Donald Bellgrau's co-authors include Richard C. Duke, Alex Franzusoff, Helena Selawry, Daniel P. Gold, Jodene K. Moore, Darcy B. Wilson, Jaime F. Modiano, Claire Coeshott, Julie Lang and Clyde F. Barker and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Donald Bellgrau

77 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A role for CD95 ligand in preventing graft rejection

1995 979 citations Donald Bellgrau, Daniel P. Gold et al. profile →

Peers

Countries citing papers authored by Donald Bellgrau

Since Specialization

Citations

This map shows the geographic impact of Donald Bellgrau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Bellgrau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Bellgrau more than expected).

Fields of papers citing papers by Donald Bellgrau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Bellgrau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Bellgrau. The network helps show where Donald Bellgrau may publish in the future.

Co-authorship network of co-authors of Donald Bellgrau

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Bellgrau. A scholar is included among the top collaborators of Donald Bellgrau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Bellgrau. Donald Bellgrau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nfatc2 and Tob1 Have Non-Overlapping Function in T Cell Negative Regulation and Tumorigenesis 2014 ·PLoS ONE ·(unknown), Qing Zhou, (unknown), (unknown), David G. Coffey, Steven L. Highfill, Christoph Bucher, Ilze Matise, Herbert C. Morse, Maeve O’Sullivan, Melissa M. Schutten, Charles S. Johnson, Donald Bellgrau, Bruce R. Blazar, Jaime F. Modiano	10
2	A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance 2014 ·PLoS ONE ·Thomas H. King, (unknown), Zhimin Guo, (unknown), Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Zong Ho, William E. Delaney, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shikha Shrivastava, Y.-J. Lee, Shyamasundaran Kottilil, Donald Bellgrau, Timothy C. Rodell, David Apelian	55
3	MHC-dependent desensitization of intrinsic anti-self reactivity 2008 ·Cancer Immunology Immunotherapy ·Cristan M. Jubala, (unknown), (unknown), Julie Lang, (unknown), David G. Coffey, Karen M. Helm, Jerome Schaack, Monika Baier, Gary Cutter, Donald Bellgrau, Jaime F. Modiano	6
4	FAS ligand gene transfer for cancer therapy 2005 ·Jaime F. Modiano, (unknown), Cristan M. Jubala, (unknown), Jerome Schaack, Donald Bellgrau	5
5	Nicotine Activates Nuclear Factor of Activated T Cells c2 (NFATc2) and Prevents Cell Cycle Entry in T Cells 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Ashley Frazer‐Abel, Shairaz Baksh, Susan Fosmire, (unknown), Angela Pierce, (unknown), D. Scott Linthicum, Steven J. Burakoff, Teresa Coons, Donald Bellgrau, Jaime F. Modiano	24
6	Enhancing antimelanoma immune responses through apoptosis 2003 ·Cancer Gene Therapy ·(unknown), Juan Sun, Susan Fosmire, Kenneth W. Hance, Marcia L. Padilla, Michelle G. Ritt, David M. Getzy, Richard C. Duke, Stephen J. Withrow, Susan E. Lana, David T. Matthiesen, Steven Dow, Donald Bellgrau, Gary Cutter, Stuart C. Helfand, Jaime F. Modiano	38
7	Murine heart transgenic Fas ligand expression protects against allograft rejection 2002 ·Transplantation Proceedings ·(unknown), Richard C. Duke, (unknown), David P. Nelson, Donald Bellgrau	2
8	The Identification of a Novel T Cell Activation State Controlled by a Diabetogenic Gene 2001 ·The Journal of Immunology ·Jodene K. Moore, Robert I. Scheinman, Donald Bellgrau	8
9	Promiscuous activation and cell cycle entry in T cells from autoimmune animals 1999 ·Transplantation Proceedings ·Jodene K. Moore, Donald Bellgrau	3
10	Apoptosis and CD95 Ligand in Immune Privileged Sites 1999 ·International Reviews of Immunology ·Donald Bellgrau, Richard C. Duke	8
11	Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes 1995 ·Journal of Neuroimmunology ·Monika Fleshner, Donald Bellgrau, Linda R. Watkins, Mark L. Laudenslager, Steven F. Maier	33
12	Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors 1994 ·Journal of Neuro-Oncology ·Carol A. Kruse, Patric M. Schiltz, Donald Bellgrau, Qingzhong Kong, Bette K. Kleinschmidt‐DeMasters	28
13	Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma 1993 ·Journal of Neuro-Oncology ·Carol A. Kruse, Dawn H. Mitchell, Bette K. Kleinschmidt‐DeMasters, Donald Bellgrau, (unknown), José Roberto Postali Parra, Qingzhong Kong, Kevin O. Lillehei	24
14	Allogeneic tumor-specific cytotoxic T lymphocytes 1992 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Carol A. Kruse, Donald Bellgrau	18
15	Specificity of rat T cell receptor V_β chain usage in proliferative responses to staphylococcal enterotoxin B 1992 ·European Journal of Immunology ·Karen S. Sellins, Donald Bellgrau, Daniel P. Gold	10
16	CYCLOSPORINE-INDUCED TOLERANCE TO INTRATESTICULAR ISLET XENOGRAFTS 1990 ·Transplantation ·Donald Bellgrau, Helena Selawry	19
17	T lymphocyte function in vivo. Ambivalence of the class I MHC antigen-reactive subset. 1985 ·PubMed ·Philip D. Hodgkin, Michael Agostino, Karen S. Sellins, Stephen J. Prowse, Donald Bellgrau, Kevin J. Lafferty	7
18	Induced tolerance in F1 rats to anti-major histocompatibility complex receptors on parental T cells. Implications for self tolerance. 1981 ·The Journal of Experimental Medicine ·Donald Bellgrau, Dawn E. Smilek, Darcy B. Wilson	18
19	Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T-cell receptors specific for major histocompatibility complex alloantigens. 1979 ·The Journal of Experimental Medicine ·Donald Bellgrau, Darcy B. Wilson	42
20	Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells. 1978 ·The Journal of Experimental Medicine ·Donald Bellgrau, Darcy B. Wilson	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact